Elucidating the effects of modulating a novel target on synapse loss in models of plaque deposition and Abeta-mediated toxicity

Project Details

StatusFinished
Effective start/end date1/04/1930/04/23

Funding

  • Autifony Therapeutics Ltd: £144,381.30